Comment on

• Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.

  Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Diabetic Retinopathy Clinical Research Network, et al. N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18. N Engl J Med. 2015. PMID: 25692915 Free PMC article. Clinical Trial.
• Targeting the Effect of VEGF in Diabetic Macular Edema.

  Cheung CM, Wong TY. Cheung CM, et al. N Engl J Med. 2015 Jul 30;373(5):479. doi: 10.1056/NEJMc1505684. N Engl J Med. 2015. PMID: 26222566 No abstract available.
• Targeting the Effect of VEGF in Diabetic Macular Edema.

  Schlottmann PG. Schlottmann PG. N Engl J Med. 2015 Jul 30;373(5):480. doi: 10.1056/NEJMc1505684. N Engl J Med. 2015. PMID: 26222567 No abstract available.
• Targeting the Effect of VEGF in Diabetic Macular Edema.

  Adamis AP, Ehrlich J, Fung A. Adamis AP, et al. N Engl J Med. 2015 Jul 30;373(5):480-1. doi: 10.1056/NEJMc1505684. N Engl J Med. 2015. PMID: 26222568 No abstract available.